| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b45ce7a40a7a3ac1dcec06ae62639d40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_675890b893066a28f59cbf5b8aa780c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate |
2005-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24a8af271681ecae93975016cfc7808b |
| publicationDate |
2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006065146-A2 |
| titleOfInvention |
Fluorescent contrast agents |
| abstract |
The invention relates to contrast agents for imaging of diseases associated with inflammations. More specifically the invention provides optical imaging contrast agents for imaging of activated leukocytes and methods for imaging of such. The contrast agent changes its fluorescent properties upon reaction with oxidants produced by the activated leukocytes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7906106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8758727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009139972-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009139972-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2009246822-B2 |
| priorityDate |
2004-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |